NUZ 5.26% 20.0¢ neurizon therapeutics limited

Ann: Second Patient In Human Cancer Trial Begins Treatment, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,977 Posts.
    lightbulb Created with Sketch. 1763
    I still think it should have been listed as price sensitive but I am not a expert on announcements and would think ASIC knows best here.

    The good news is two new patients being screened for suitability, canine trials in progress and one would expect to have news on progress within the next month.

    I have knocked PAA for not updating patients well they have at least told us what is going on so I also see this good
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.010(5.26%)
Mkt cap ! $98.34M
Open High Low Value Volume
20.0¢ 20.5¢ 19.5¢ $86.20K 429.7K

Buyers (Bids)

No. Vol. Price($)
3 67508 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 36444 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.